| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-05-21 | Mr. J. Lindsey AlleyMD & CFO | -7.10k | 0.00 | Other Disposition | - | 81.57k | -8.01% |
| 2026-05-21 | Mr. Scott Lee BeiserCo-Chairman & Director | -6.27k | 941.38k | Derivative Exercise and Sale | 150.26 | 0.00 | - |
| 2026-05-15 | Mr. Paul Eric SiegertCo-Chairman, Global Co-Head of Financial Restructuring & Director | -9.36k | 1.41M | Sale to Issuer | 150.35 | 375.30k | -2.43% |
| 2026-05-19 | Mr. Christopher M. CrainMD, General Counsel & Secretary | -2.11k | 316.79k | Sale to Issuer | 150.35 | 49.13k | -4.11% |
| 2026-05-15 | Mr. Todd John CarterMD & Director | -13.71k | 2.06M | Sale to Issuer | 150.35 | 76.20k | -15.25% |
| 2026-05-15 | Mr. Irwin N. GoldCo-Chairman & Chairman of the Board | -4.62k | 694.47k | Sale to Issuer | 150.35 | 1.06M | -0.43% |
| 2026-05-15 | Mr. Scott Lee BeiserCo-Chairman & Director | -6.50k | 976.82k | Sale to Issuer | 150.35 | 793.92k | -0.81% |
| 2026-05-15 | Mr. J. Lindsey AlleyMD & CFO | -2.98k | 448.49k | Sale to Issuer | 150.35 | 67.37k | -4.24% |
| 2026-05-15 | Mr. Scott Joseph AdelsonCEO & Director | -11.09k | 1.67M | Sale to Issuer | 150.35 | 867.83k | -1.26% |
| 2026-04-01 | Mr. Christopher M. CrainMD, General Counsel & Secretary | -500.00 | 71.70k | Derivative Exercise and Sale | 143.40 | 0.00 | - |
| 2026-02-06 | Mr. Robert A. SchriesheimLead Independent Director | -5.00k | 854.30k | 売り | 170.86 | 27.98k | -15.16% |
| 2026-01-02 | Mr. Christopher M. CrainMD, General Counsel & Secretary | -500.00 | 87.09k | Derivative Exercise and Sale | 174.17 | 0.00 | - |
| 2025-12-05 | Mr. Irwin N. GoldCo-Chairman & Chairman of the Board | -5.00k | 0.00 | Derivative Exercise and Sale | - | 0.00 | - |
| 2025-11-26 | Mr. Christopher M. CrainMD, General Counsel & Secretary | -1.20k | 0.00 | Derivative Exercise and Sale | - | - | - |
| 2025-11-10 | Mr. Scott Lee BeiserCo-Chairman & Director | -8.00k | 0.00 | Derivative Exercise and Sale | - | 0.00 | - |
| 2025-09-16 | Mr. Irwin N. GoldCo-Chairman & Chairman of the Board | -6.81k | 1.38M | Derivative Exercise and Sale | 202.75 | 0.00 | - |
| 2025-09-02 | Mr. Christopher M. CrainMD, General Counsel & Secretary | -500.00 | 98.11k | Derivative Exercise and Sale | 196.22 | 0.00 | - |
| 2025-08-27 | Mr. Paul Eric SiegertCo-Chairman, Global Co-Head of Financial Restructuring & Director | -40.00k | 8.00M | Derivative Exercise and Sale | 199.95 | 0.00 | - |
| 2025-08-05 | Mr. Scott Joseph AdelsonCEO & Director | -114.40k | 0.00 | Other Disposition | - | 993.32k | -10.33% |
| 2025-07-18 | Mr. Paul Eric SiegertCo-Chairman, Global Co-Head of Financial Restructuring & Director | -2.82k | 0.00 | Other Disposition | - | 427.48k | -0.65% |
| 2025-07-14 | Ms. Gillian Beth ZuckerIndependent Director | -200.00 | 38.33k | Automatic Disposition | 191.65 | 5.53k | -3.49% |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。